Normal view MARC view ISBD view

Antibacterial potential of silver nanoparticles synthesized using Madhuca longifolia flower extract as a green resource. [electronic resource]

By:

Patil, Maheshkumar Prakash

Contributor(s):

Producer: 20190114Description: 184-189 p. digitalISSN:

1096-1208

Subject(s):

Online resources:

Available from publisher's website

In: Microbial pathogenesis vol. 121

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

1461 Aldehyde dehydrogenase 2 protects against oxidative stress associated with pulmonary arterial hypertension.
by Xu, Tao
1462 The Therapeutic Effects of Human Mesenchymal Stem Cells Primed with Sphingosine-1 Phosphate on Pulmonary Artery Hypertension.
by Kang, Hyunsook
1463 Angiotensin-converting enzyme inhibition delays pulmonary vascular neointimal formation.
by Okada, K
1464 Resveratrol prevents monocrotaline-induced pulmonary hypertension in rats.
by Csiszar, Anna
1465 The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS.
by Guerard, Pascal
1466 Role of the gap junctions in the contractile response to agonists in pulmonary artery from two rat models of pulmonary hypertension.
by Billaud, Marie
1467 ACE2 activation confers endothelial protection and attenuates neointimal lesions in prevention of severe pulmonary arterial hypertension in rats.
by Li, Gang
1468 Targeted delivery of pulmonary arterial endothelial cells overexpressing interleukin-8 receptors attenuates monocrotaline-induced pulmonary vascular remodeling.
by Fu, Jinyan
1469 YAP determines the cell fate of injured mouse hepatocytes in vivo.
by Miyamura, Norio
1470 Potassium Channel Subfamily K Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension.
by Antigny, Fabrice
1471 Rosuvastatin attenuates monocrotaline-induced pulmonary hypertension via regulation of Akt/eNOS signaling and asymmetric dimethylarginine metabolism.
by Pei, Yingzi
1472 Rosuvastatin, sildenafil and their combination in monocrotaline-induced pulmonary hypertension in rat.
by Jasińska-Stroschein, Magdalena
1473 Inhalation of the BK(Ca)-opener NS1619 attenuates right ventricular pressure and improves oxygenation in the rat monocrotaline model of pulmonary hypertension.
by Revermann, Marc
1474 Angiotensin-converting enzyme 2 activation ameliorates pulmonary endothelial dysfunction in rats with pulmonary arterial hypertension through mediating phosphorylation of endothelial nitric oxide synthase.
by Li, Gang
1475 Hypoxia augments NaHS-induced ANP secretion via KATP channel, HIF-1α and PPAR-γ pathway.
by Yu, Lamei
1476 Icotinib Attenuates Monocrotaline-Induced Pulmonary Hypertension by Preventing Pulmonary Arterial Smooth Muscle Cell Dysfunction.
by Peng, Li-Yao
1477 Propylthiouracil attenuates monocrotaline-induced pulmonary arterial hypertension in rats.
by Sun, Cheuk-Kwan
1478 Attenuation of monocrotaline-induced pulmonary arterial hypertension in rats by rosuvastatin.
by Li, Xiao-Lin
1479 Enhanced Ca(2+)-sensing receptor function in idiopathic pulmonary arterial hypertension.
by Yamamura, Aya
1480 Inhibition of nuclear factor-κB in the lungs prevents monocrotaline-induced pulmonary hypertension in mice.
by Li, Li